07 Jun 2013, BioSpectrum Bureau , BioSpectrum
New Delhi: UnitedLex, a global provider of legal and business technology consulting services, announced its selection to be the primary managed document review provider to Pfizer, the world's largest research-based pharmaceutical company.
UnitedLex will ensure global delivery of Pfizer's extensive managed document review process by supporting real-time communications with internal and external counsel through the most advanced video conferencing capabilities, rigorous quality control processes, daily metrics reporting, proprietary multi-shore workflow and defined project intake and delivery methods. UnitedLex manages document review for Fortune 500 companies and AmLaw 100 law firms from facilities in the US, India, the UK and Israel.
"Pfizer has been an innovator in restructuring the litigation management process and being selected to control one of its most critical functions is an honor," said Mr Dave Deppe, president of UnitedLex. "With more than 750 professionals in nine global offices and two data centers, UnitedLex is ideally suited to partner with a company of Pfizer's caliber and sophistication."
"Pfizer's discovery model calls for a collaborative partner with extensive global delivery capability that embraces the operational efficiencies and advanced technologies required in today's discovery environment, while also remaining cognizant of the cost pressures large corporations face," said Mr Ed Gramling, Pfizer's Discovery Counsel. "UnitedLex has proven they can deliver a superior work product in conjunction with highly competitive pricing and we are excited to have them on board," he said.
"Each year UnitedLex handles large, complex, ‘bet-the-company' litigation matters for the world's best-run companies. We look forward to the opportunity to apply our expertise to Pfizer's most important litigation matters," said Mr Ryan Reeves, senior vice president of US operations for UnitedLex.
UnitedLex was awarded the position of Pfizer's primary global document review provider after several pilot projects, intense calibration and scalability exercises, rigorous quality validations and many in depth operational and security audits. Towards the end of the diligence period, members of Pfizer's legal team traveled to the UnitedLex Gurgaon, India, facility in January of 2013.
Mr Ryan Reeves will lead the initiative on behalf of UnitedLex to ensure continued improvements across the established Pfizer Discovery platform with ultimate focus on quality of work product delivered from the UnitedLex global delivery platform.